The role of cyclin-dependent kinases in miR-193a5p regulating ovarian cancer cell proliferation and epithelial mesenchymal transformation

doi:10.12047/j.cjap.5888.2020.039

Abstract

Abstract: Objective: To investigate whether miR-193a-5p targets CDK14 and regulates the proliferation and epithelial-mesenchymal transition (EMT) of ovarian cancer cell line OVAC. Methods: TargetScanHuman was used to analyze the match between miR-193a-5p and CDK14, and then miRNA assay was used to detect whether miR-193a-5p targeting CDK14; miR-193a-5p mimics overexpression or miR-193a-5p inhibitor knockdown in the case of low miR-193a-5p, the expression levels of CDK14, EMT-related proteins E-cadherin, vimentin, fibronectin and N-cadherin were detected by immunoblotting, and the proliferation of ovarian cancer cells OVAC was detected by CCK-8, and the cell viability of cancer cell OVAC was detected by MMT. Results: miR-193a-5p targeted the 3'UTR of CDK14; after overexpression of miR-193a-5, the expression of CDK14 was decreased, the expression of EMT-related protein E-cadherin was increased, and the expressions of vimentin, fibronectin and N-cadherin were decreased. The proliferation and cell viability of ovarian cancer cell line OVAC were increased. Meanwhile, after knocking down miR-193a-5p, the expression of CDK14 was increased, and the expression of EMT-related protein E-cadherin was decreased, while the expression levels of vimentin, fibronectin and N-cadherin were increased, and the proliferation and cell viability of ovarian cancer cell line OVAC were decreased. Conclusion: miR-193a-5p reduces the proliferation, cell viability and EMT of ovarian cancer cell line OVAC by targeting the 3 'UTR of CDK14.

Key words: miR-193a-5p, CDK14, ovarian cancer, OVAC, proliferation, EMT

CLC Number:

R737-31

YANG Zun-jing, DU Xian-ling. The role of cyclin-dependent kinases in miR-193a5p regulating ovarian cancer cell proliferation and epithelial mesenchymal transformation[J]. CJAP, 2020, 36(2): 176-179.

References

[1] 杨佳欣, 沈铿, 吴令英, 等. 卵巢上皮性癌BRCA基因检测的中国专家讨论[J]. 中华妇产科杂志, 2017, 52(1): 8-10.
[2] 陈颖, 龙启芳. ER、HNF-1β及COX-2在子宫内膜异位相关性卵巢癌中的表达及临床意义[J]. 重庆医学, 2017, 46(27): 3801-3803.
[3] Feng Y, Hang W, Sang Z, et al. Identification of exosomal and nonexosomal microRNAs associated with the drug resistance of ovarian cancer[J]. Mol Med Rep, 2019, 19(5): 3376-3392.
[4] Ren X, Zhang H, Cong H, et al. Diagnostic model of serum miR-193a-5p, HE4 and CA125 improves the diagnostic efficacy of epithelium ovarian Cancer[J]. Pathol Oncol Res, 2018, 24(4): 739-744.
[5] 罗凯, 黎谢梦丹, 石兴源, 等. 人CDK14基因表达荧光定量PCR检测方法的建立及初步应用[J]. 现代检验医学杂志, 2017, 32(32): 29.
[6] Zhang W, Liu R, Tang C, et al. PFTK1 regulates cell proliferation, migration and invasion in epithelial ovarian cancer[J]. Int J Biol Macromol, 2016, 85: 405-416.
[7] Liu M, Shi S, Li K, et al. Knockdown of PFTK1 expression by RNAi inhibits the proliferation and invasion of human non-small lung adenocarcinoma cells[J]. Oncol Res Fea Preclin Clin Cancer Ther, 2016, 24(3): 181-187.
[8] 彭健, 张耀婷, 李慧, 等. 啤酒酵母野生型和缺失型菌株的比较蛋白组学分析[J]. 中国现代医学杂志, 2017, 27(21): 18-24.
[9] 孔令宇, 席錾, 马文婷, 等. 缺氧缺糖诱导心肌细胞损伤中Notch信号对HIF-α及自噬相关基因Beclin1, LC3Ⅰ, LC3Ⅱ表达的影响[J]. 中国应用生理学杂志, 2019, 35(2): 165-168.
[10]王爽, 汪彩霞, 林蓓. 外泌体在卵巢癌诊治中的研究现状[J]. 中国实用妇科与产科杂志, 2018, 34(4): 462-464.
[11]王红磊, 肖奕, 武力, 等. miR -449a对人乳腺癌细胞MCF -7增殖及迁移能力的影响[J]. 中国应用生理学杂志, 2017, 33(6): 508-513.
[12]马瀚博, 李怀芳. MicroRNA在卵巢癌早期诊断及预后中应用的研究进展[J]. 中华全科医学, 2018, 16(5): 826-829.
[13]Petrillo M, Zannoni GF, Beltrame L, et al. Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies[J]. Ann Oncol, 2016, 27(4): 625-634.
[14]Zhang H, Wang Q, Zhao Q, et al. MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1[J]. J Ovarian Res, 2013, 6(1): 84.
[15]Ding C, He J, Liao W, et al. Regulation of WNT/β-catenin signaling by carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (CAD) in colorectal cancer cell[J]. Int J Clin Exp Med, 2017, 10(12): 16243-16253.
[16]钱佶, 王燏婵, 张学俭. CDK14对人食管癌细胞增殖的影响及其可能机制研究[J]. 胃肠病学, 2016, 21(10): 585-591.
[17]Wang B, Zou A, Ma L, et al. miR-455 inhibits breast cancer cell proliferation through targeting CDK14[J]. Eur J Pharmacol, 2017, 807: 138-143.
[18]Zheng L, Zhou Z, He Z. Knockdown of PFTK1 inhibits tumor cell proliferation, invasion and epithelial-to-mesenchymal transition in pancreatic cancer[J]. Int J Clin Exp Pathol, 2015, 8(11): 14005.
[19]Zhang W, Liu R, Tang C, et al. PFTK1 regulates cell proliferation, migration and invasion in epithelial ovarian cancer[J]. Int J Biol Macromol, 2016, 85: 405-416.